Wang S, Han S, Cheng W, Miao R, Li S, Tian X, & Kan Q. (2022). Design, Synthesis, and Biological Evaluation of 2-Anilino-4-Triazolpyrimidine Derivatives as CDK4/HDACs Inhibitors. Dove Medical Press.
Chicago Style (17th ed.) CitationWang S, Han S, Cheng W, Miao R, Li S, Tian X, and Kan Q. Design, Synthesis, and Biological Evaluation of 2-Anilino-4-Triazolpyrimidine Derivatives as CDK4/HDACs Inhibitors. Dove Medical Press, 2022.
MLA (9th ed.) CitationWang S, et al. Design, Synthesis, and Biological Evaluation of 2-Anilino-4-Triazolpyrimidine Derivatives as CDK4/HDACs Inhibitors. Dove Medical Press, 2022.
Warning: These citations may not always be 100% accurate.